The X-linked adrenoleukodystrophy (ALD) gene was identified recently a
nd is predicted to encode a 745-amino-acid peroxisomal membrane protei
n. Strategies have been designed for the search for mutations in the A
LD gene in patients. Several mutations have now been found and it seem
s that many different mutations are responsible for ALD. There is no s
traightforward correlation between genotype and phenotype since the sa
me mutation can cause different ALD phenotypes in the same family. How
ever, once a mutation has been found in a family, it can be traced in
all at-risk individuals of that family, both post- and prenatally, wit
hout the need for very long-chain fatty acid (VLCFA) analysis. Segrega
tion analysis with extragenic and intragenic polymorphisms may remain
useful in families where mutation analysis is not possible for practic
al reasons; VLCFA analysis and measurement of the peroxisomal beta-oxi
dation with C-26:0 fatty acid as a substrate will remain the alternati
ve. We also briefly discuss the possibilities of DNA diagnosis for oth
er peroxisomal disorders.